Is cibinqo a jak inhibitor?

Is Cibinqo (abrocitinib) a JAK inhibitor?

Yes. Cibinqo (abrocitinib) is a Janus kinase (JAK) inhibitor. It works by blocking JAK-related signaling pathways involved in inflammatory processes. [1]

Which JAKs does Cibinqo inhibit?

Abrocitinib is described as a selective JAK inhibitor that targets JAK1 activity. [1]

Why does that matter for patients?

Because it is a JAK inhibitor, Cibinqo is used to treat inflammatory conditions where JAK signaling plays a role, and it shares the class’s general safety considerations tied to immune signaling effects. [1]

Source

[1] https://www.drugs.com/cibinqo.html